Related Experiment Video

Updated: Aug 30, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Phospholipase D and choline kinase: their role in cancer development and their potential as drug targets

Agustín Rodríguez-González1, Ana Ramírez de Molina, Joaquín Benítez-Rajal

  • 1Instituto de Investigaciones Biomédicas, CSIC, Madrid, Spain.

Progress in Cell Cycle Research
|November 5, 2003
PubMed

Insights

Cancer cells develop from genetic changes affecting cell growth pathways, particularly phospholipid homeostasis. Choline kinase and phospholipase D are identified as promising novel targets for developing new cancer chemotherapeutic agents.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Malignant transformation arises from accumulated genetic alterations impacting signal transduction pathways.
  • Phospholipid homeostasis regulation is a critical pathway frequently disrupted in cancer.
  • Understanding altered molecular components in transformed cells is essential for developing targeted cancer therapies.

Purpose of the Study:

  • To identify novel molecular targets for chemotherapeutic interventions against cancer cells.
  • To investigate the role of phospholipid homeostasis regulators in malignant transformation.
  • To provide evidence for choline kinase and phospholipase D as potential drug targets.

Main Methods:

  • Analysis of genetic alterations in signal transduction pathways.
  • Investigation of molecular components regulating phospholipid homeostasis.
  • Evaluation of choline kinase and phospholipase D in the context of cancer transformation.

Main Results:

  • Genetic alterations in cancer cells disrupt normal cell growth regulation.
  • Key enzymes involved in phospholipid metabolism, choline kinase and phospholipase D, are implicated.
  • Evidence suggests these enzymes are altered upon cellular transformation.

Conclusions:

  • Choline kinase and phospholipase D represent promising novel targets for cancer drug development.
  • Targeting phospholipid homeostasis pathways offers a rational approach for designing new chemotherapeutic agents.
  • Further research into these targets could lead to improved cancer treatments.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Synthesis of Phosphatidylcholine in the ER Membrane01:27

Synthesis of Phosphatidylcholine in the ER Membrane

The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...